Kevin Robert Lind

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christopher Sullivan, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kevin Robert Lind

Form 4 holding Director

Avalo Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,105
Estimated value
$12,499
Report date
30 Jun 2026
Price
$14.74
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Longboard Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
255,377
Estimated value
Report date
13 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Longboard Pharmaceuticals, Inc.

Security class
Retention Restricted Stock Units
Shares / value
22,000
Estimated value
Report date
25 Oct 2024
Price
Ownership
Direct
Underlying class
Voting Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Longboard Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
02 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Longboard Pharmaceuticals, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
02 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kevin Robert Lind

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .